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Abstract
Context
Acute copper sulphate poisoning is an unusual
event, rarely following parenteral exposure,
complicated by toxicological effects as
haemolytic anaemia, methaemoglobinaemia ,
hepato-renal damage and acute rhabdomyolysis.
Currently, the therapeutic management ignores
unique classes of evidence and is mainly based on
supportive and chelation therapies. Case details.
This case report describes acute copper sulphate
poisoning in a 37-year-old man who attempted
suicide by self-injecting an unknown amount of
copper sulphate. Within three days the patient
developed severe intravascular haemolysis and
rhabdomyolysis. Initial therapy relied on intensive
supportive care with fluids administration,
electrolyte correction and packed red blood cells
transfusion. The D-penicillamine (30 mg/Kg/day
per os) was prescribed as chelation therapy by the
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poison control centre. The N-acetilcysteine and
ascorbic acid were administered to prevent
further oxidative stress. Later on, two sessions of
therapeutic plasma exchange were performed in
order to support the drug therapy. Haemolysis and
rhabdomyolysis reversed throughout the hospital
stay. Discussion. In this case the antidotic and
antioxidant therapy resulted effective to reverse
haemolysis and rhabdomyolysis and to prevent
hepatic and renal damage. Moreover, this case
underlies that therapeutic plasma exchange
should be considered as an additive measure to
undertake since the earlier stages of the
emergency intervention.
 
Learning point for clinician
Acute copper sulphate poisoning is an event
complicated by toxicological effects: haemolytic
anaemia, methaemoglobinaemia, hepato-renal
damage, acute rhabdomyolysis. The therapeutic
management ignores unique classes of evidence
and is based on supportive and chelation
therapies. In this case: i) the antidotic and
antioxidant therapy resulted effective to reverse
haemolysis and rhabdomyolysis and to prevent
hepatic and renal damage, ii) therapeutic plasma
exchange should be considered as an additive
measure to undertake.
 
Introduction
Copper Sulphate (CuS) is a salt formed by treating
cupric oxide with sulphuric acid and it is mainly
used in metal industry and agriculture, particularly
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in compounds such as fertilizers, insecticides and
fungicides. Chronic intoxication is often
occupational related. Acute Copper Sulphate
Poisoning (ACuSP), instead, usually results from
oral ingestion with suicidal purpose, and rarely
from parenteral exposure: only four cases of
parenteral ACuSP have been reported in literature
to date.  Therefore, consensus regarding the
therapeutic management is still missing.  This
report presents a case of intravenous ACSP as
suicide attempt.
 
Clinical Case
A 37-year-old man was admitted at his local
Emergency Department (ED). Three hours
previously, he self-injected intravenously an
unknown amount of a solution of CuS as suicidal
attempt. The patient had a history of heroin and
cocaine use disorders (DSM-5). At the admission,
he was fully conscious, Glasgow Coma Scale (GCS)
15, T 36.5°C, Respiratory Rates (RR) 18 breaths/min,
SpO2 96% on room air, Blood Pressure (BP) 105/75
mmHg and Heart Rate (HR) 120 beats/min. Physical
examination was normal. He presented tremors
and diffuse myalgia. Laboratory results were within
the range of normality (Table 1). Serum Copper
(Cu) levels were 263 μ/dL (normal range 70-140
μ/dL) 24 hours after admission. On day 3, the
patient was moved to the ED of Umberto I,
Policlinico of Rome. At ED admission, the patient
was alert and oriented, GCS 15, T 38°C, RR 18
breaths/min, SpO  96%, BP 130/70 mmHg, HR 72
beats/min. Physical examination revealed pallor,
jaundice, brown to red urines and signs of
1,2,3,4
1
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extravasation by the antecubital area of both
arms (Figure 1). He was complaining epigastric
pain. Laboratory findings showed: normochromic
normocytic anaemia with signs of intravascular
haemolysis, rhabdomyolysis and rising levels of
methaemoglobin (Table 1). The patient received
fluids therapy (0.9% NaCl), electrolyte correction
(KCl, MgSO4 and CaCl2) and was transfused with 4
Units of Packed Red Blood Cells. Moreover,
piperacillin/tazobactam and clindamycin were
administered for peri-injection cellulitis, salicylic
acid as antipyretic and omeprazole for gastric
protection. The poison control centre proposed to
administer N-acetilcysteine at the loading dose of
150 mg/Kg in 500 ml of Dextrose-Water 5% (D5W)
i.v. over 120 minutes, then 300 mg/Kg/day in 500 ml
of D5W i.v.; D-penicillamine (30 mg/Kg/day per os);
ascorbic acid 8 g/500 ml of 0.9% NaCl at the rate of
21 ml/h. As critical condition was persisting,
Therapeutic Plasma Exchange (TPE) was
performed on day 5 and on day 6 in order to
support the drug therapy, and serum Cu levels
were assessed immediately prior and after each
session (Figure 2). TPE was carried out using the
continuous flow separator, exchanging 1000 ml of
plasma with 5% human albumin solution, halting
both the procedure at the onset of fever and
hypotension. On day 7 the patient was transferred
to the intensive care unit and then to the surgery
unit for wounds toilet. On day 12 the patient was
moved to the psychiatric unit and on day 13
D-penicillamine was discontinued due to
increasing liver function tests. On day 22 he was
admitted to the medical department to continue
the diagnostic and therapeutic iter. On day 32 he
was finally discharged asymptomatic and with
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normal laboratory values (Table 1).
 
Discussion
As an essential trace element involved in many
enzymatic reaction, the human body contains
from 50 to 120 mg of Cu. The latter is mainly
absorbed through stomach and duodenum and it
is characterized by a rapid serum peak reached
after 1-3 hours from oral intake. Alfa-2-globulin-
ceruloplasmin transport up to 80% of Cu, while the
remaining part is loosely bound to amino acids,
vitamins and albumin. Cu is stored in the liver by
metallothionein and has an enterohepatic cycle,
being excreted mainly through the bile. Only a
minor amount of Cu is eliminated by renal
excretion. In acute poisoning, transport
mechanisms are reversed and Cu is mostly
carried by albumin, making a toxic metal-protein
complex. CuS toxicity mainly affects red blood
cells, hepatocytes and myocytes and it is
proportional to the CuS’s intracellular
concentration. Cu inhibits both glucose-
6-phosphate dehydrogenase and glutathione
reducing the free radicals scavenging activities.
Moreover, Cu increases cell membrane
permeability through the inhibition of the
NA+/K+ATPase pump. This process eventually leads
to intravascular haemolysis, rhabdomyolysis and
centrolobular necrosis with hepatitis. Furthermore,
ACuSP causes acute tubular necrosis in the 20-40%
of cases, mainly through a direct and an indirect
toxic effect which follows hemoglobinuria,
myoglobinuria and hypovolemia.  When ACuSP
follows CuS ingestion well known gastrointestinal
5
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manifestations occur probably linked to the direct
contact of the metal with the gastrointestinal
mucosa. Moreover these signs are also
documented after voluntary parenteral ACuSP.3
The management of ACuSP is mainly symptomatic
and supportive including fluids administration,
electrolyte correction and packed red blood cells
transfusion. Due to the CuS caustic effect,
endoscopy rather than gastric lavage and
activated charcoal should be performed within
the first 24 hours postingestion. As long as
methemoglobin concentrations are greater than
20% to 30% (or at lower levels in patients with
anemia, underlying pulmonary or cardiovascular
disease) methylene blue is recommended in
addition to oxygen therapy at an initial dose of 1
mg/kg IV over 5 to 30 minutes, which may be
repeated one hour later. To the best of our
knowledge, there are limited data regarding the
use of the chelation therapy in the setting of
ACuSP. The management of patients with Wilson
disease provides most of the data concerning its
dosing and efficacy. Cu intoxication suggests that
chelation therapy should be initiated when
hematologic or hepatic complications as well as
other manifestations of severe poisoning are
present, and should be continued as long as blood
Cu remains above normal values or as long as
symptomatology persists.  The D-penicillamine,
British Anti-Lewisite (BAL) and Ethylene Diamine
Tetra Acetate (EDTA) have been used as
antidotes.  The D-penicillamine is an orally
bioavailable monothiol chelator currently used in
the treatment of lead, mercury and copper
toxicity. Through chelation of unbound Cu ions, it
prevents them to participate in redox reactions
6
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and it increases their urinary excretion in patients
with normal renal function. The recommended
dose is 20–30 mg/kg/day by 3-4 administrations.
Hepatic recovery and survival rates are strongly
enhanced by both early intake and exposure
interruption. Nevertheless, D-penicillamine may
cause aplastic anemia, agranulocytosis, and renal
and pulmonary disease.  When oral intake of
D-penicillamine is contraindicated, intramuscular
administration of BAL is recommended. The latter
promotes copper excretion though biliary
elimination and therefore it should be preferred in
patients with renal failure. The recommended dose
is 3.0 to 5.0 mg/kg/4-6 hours in first two days and
tailed off over a total of 7-11 days. Main adverse
reactions include urticaria and persistent
hyperpyrexia. Another parenteral option is
represented by EDTA, which should be carefully
administrated in presence nephropathy, as it
carries the risk of acute tubular necrosis. The dose
of this agent is 75 mg/Kg/day IM or slow IV infusion
given by 3-6 administrations. Haemodialysis is
indicated only in case of persistent renal failure.
TPE removes large molecular weight substances,
expecially those which are highly bounded to
plasma proteins. The procedure is carried out in
urgency using the continuous-flow separator,
exchanging plasma with physiologic fluids such as
5% human albumin solution or fresh frozen plasma,
closely assessing serum and apheresis plasma Cu
levels. TPE may causes a transient fall in blood-
clotting factors, nevertheless clinically significant
bleeding is rare reported. Other adverse effects
include vasovagal episodes, fluid overload or
under-replacement, and allergic or anaphylactic
reactions. Few cases of using of TPE in the setting
7
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of ACuSP are available so far.  Rapid Cu removal
may avert or bridge to liver transplantation in
patients with Wilson disease.  In ACuSP, like in
Wilsonian crisis, TPE may remove free and bound
plasmatic Cu.  Early reduction of CuS plasma
levels might prevent the further toxic deposition,
moreover it may provide a plasmatic
redistribution of tissue Cu not definitively settled. In
this case, after each TPE sessions there was a
“rebound effect” consisting in a rising trend of
plasmatic Cu level. Simultaneously there was an
improvement of muscle damage index and a
transient decreasing of haemoglobin levels,
probably due to the Cu fraction that flows back to
the blood compartment, causing haemolysis
(Figure 2).
 
Conclusion
ACuSP is a rare event, which usually follow extra-
parenteral exposure. However, given the high
mortality due to its related multi systemic
damage, physicians should be familiar with the
management of such cases. Treatment of ACuSP
is mainly symptomatic and supportive, including
fluids administration, electrolyte correction and
packed red blood cells transfusion. Despite the
little clinical experience in the setting of ACuSP,
D-penicillamine, BAL and EDTA are commonly used
as chelating agents. Furthermore,
N-acetylcysteine and ascorbic acid can be
administered to prevent further oxidative stress.
Even if TPE is not recommended by the American
Society for Apheresis (ASFA) guidelines in the
management of ACuSP,  this case enlightens that
9
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it might be useful in combination with antidotic
and antioxidant therapy, to reverse haemolysis
and rhabdomyolysis and to prevent hepatic and
renal damage. In conclusion TPE should be
considered as an additive measure to undertake
since the earlier stages of the emergency
intervention.
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Figure 1. X-ray image carried out 72 hours after
Copper Sulphate (CuS) parenteral exposure.
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Figure shows a CuS extravasation by the
antecubital area of both arms.
 
 
Figure 2. Copper (Cu), Haemoglobin (Hb),
Methaemoglobin (MetHb), Creatine Kinase (CK)
and Aspartate Aminotransferase (AST) blood level
determination from 3 to 168 hours after Copper
Sulphate (CuS) parenteral exposure.
Figure shows how Cu levels rapidly falls after each
session of TPE and simultaneously there is an
improvement of muscle damage index and a
transient decreasing of Hb level.
(TPE = Therapeutic Plasma Exchange)
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Table 1. Laboratory features in relation to time after
Copper Sulphate (CuS) intravenous self injection
Days after CuS i.v. self injection 1 3 5 6 32
Creatinine (0.10-1.20 mg/dL) 1.01 0.70 0.70 0.70 0.80
AST  (8-38 IU/L) 217 467 226 55 18
ALT  (12-41 IU/L) 38 86 5 29 30
a
b
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Total Bilirubin (0.35-1.00 mg/dL) - - 5.06 2.01 0.16
Direct Bilirubin (0.15-0.35 mg/dL) - 0.09 - 0.47 0.12
LDH  (135-225 IU/L) 650 3565 4345 2113 212
Creatine Kinase CK (39-308 IU/L) 154 1724 1142 449 100
CRP (>0.05 mg/dL) - 8.89 - - -
Hb  (13-17 g/dL) 15.70 9.60 7.40 8.30 13.00
HCT  (40-52 %) 47.90 26.20 19.00 23.70 40.00
MCV  (80-96 fL) 99.80 98.40 90.70 87.80 97.00
WBC  (4-10 x 10 /L) 8.10 15.41 21.89 19.22 9.34
Platelet Count (150-450 x 10 /L) 263 221 318 149 592
PT-INR  (0.80-1.20) 1.36 1.00 1.09 1.13 0.95
aPTT  (0.80-1.20 sec) 1.18 2.67 0.91 0.80 2.68
Lactate (mmol/L) 2.40 1.00 0.80 0.80 0.70
MetHb  (%) 1.00 5.20 6.30 3.90 1.10
Aspartate Aminotransferase; Alanine Aminotransferase;
Lactate Dehydrogenase; C-Reactive Protein; Haemoglobin;
Haematocrit; Mean Corpuscular Volume; Whole Blood
Count; Prothrombin Time-International Normalized Ratio;
activated Partial Thromboplastin Time; Methaemoglobin
Note: Reference values are reported in parentheses
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